Different treatment response to systemic corticosteroids according to white blood cell counts in severe COVID-19 patients.

ABSTRACT:

Background

Limited data are available in COVID-19 patients on the prediction of treatment response to systemic corticosteroid therapy based on systemic inflammatory markers. There is a concern whether the response to systemic corticosteroid is different according to white blood cell (WBC) counts in COVID-19 patients. We aimed to assess whether WBC count is related with the clinical outcomes after treatment with systemic corticosteroids in severe COVID-19.

Methods

We conducted a retrospective cohort study and analysed the patients hospitalised for severe COVID-19 and received systemic corticosteroids between July 2020 and June 2021. The primary endpoint was to compare the composite poor outcome of mechanical ventilation, extracorporeal membrane oxygenation, and mortality amon

SUBMITTER: Choi KY 

PROVIDER: S-EPMC9721443 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature